首页 | 本学科首页   官方微博 | 高级检索  
检索        

匹维溴胺治疗便秘型肠易激综合征的疗效观察
引用本文:倪扬.匹维溴胺治疗便秘型肠易激综合征的疗效观察[J].中国医院用药评价与分析,2011(7):642-643.
作者姓名:倪扬
作者单位:新津县人民医院消化内科;
摘    要:目的:观察匹维溴胺治疗便秘型肠易激综合征(IBS-C)的疗效。方法:将60例IBS-C患者随机分成治疗组30例和对照组30例,治疗组予匹维溴胺片50 mg,每日3次;对照组予枸橼酸莫沙必利片5 mg,每日3次。2组疗程均为8周。根据粪质、每周排便次数、排便困难及排便不尽感、腹痛、腹胀5个症状进行评分。计算治疗前后每组患者的症状总积分、平均积分及疗效指数。结果:治疗组治疗后总积分298分,平均(4.668±2.853)分,总有效率为83.3%;对照组治疗后总积分560分,平均(4.647±2.855)分,总有效率为63.3%;2组差异有统计学意义(P<0.01)。结论:匹维溴胺治疗IBS-C的腹痛、腹胀、便秘等症状,疗效优于莫沙必利。

关 键 词:匹维溴胺  便秘型肠易激综合征  疗效

Clinical Efficacy of Pinaverium Bromide for Constipation-predominant Irritable Bowel Syndrome
NI Yang.Clinical Efficacy of Pinaverium Bromide for Constipation-predominant Irritable Bowel Syndrome[J].Evaluation and Analysis of Drug-Use in Hospital of China,2011(7):642-643.
Authors:NI Yang
Institution:NI Yang(Dept.of Gastroenterological,Xinjin County People's Hospital,Chengdu 611430,China)
Abstract:OBJECTIVE: To evaluate the efficacy of pinaverium bromide for constipation-predominant irritable bowel syndrome(IBS-C).METHODS: 60 patients with IBS-C were randomly assigned to either treatment group(30 cases) treated with pinaverium bromide tablets(50 mg) t.i.d or control group(30 cases) treated with mosapride citrate tablets(5 mg) t.i.d for 8 weeks.The symptoms such as fecal matter,weekly defecation frequency,difficult defecation and feeling of unfinished bowel movement,abdominal pain and abdominal bloati...
Keywords:Pinaverium Bromide  Constipation-predominant irritable bowel syndrome  Curative effect  
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号